Event Detail (Archived)

Development of KB004, a Therapeutic Antibody Targeting EphA3 in Solid and Hematopoietic Cancers

  • This event already took place in November 2012
  • Auditorium, Rockefeller Research Laboratories, MSKCC, 430 E. 67th St.

Event Details

Type
Other Tri-Institutional Events
Speaker(s)
Martin Lackmann, Ph.D., associate professor, Monash University
Open to
Public
Host
Dr. Dimitar Nikolov
Reception
Refreshments, 1:45 p.m.
Contact
Julie Kwan
Phone
(212) 639-2668
Sponsor
Liz Snyder
(212) 639-2540
snydere@mskcc.org

Related News

The value of publishing negative data

Scientific publishing has a bias against negative results and that hurts science, says Tim Fessenden, editor of Life Science Alliance, a publication of Rockefeller University Press. Here’s how journal editors can help.

Researchers identify gene that calms the mind and improves attention in mice

Study demonstrates that the Homer1 gene improves focus by reducing "noise" in the prefrontal cortex, with implications for the study of ADHD and other attention disorders.

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

Related Events

Pre-Seminar Coffee and Cookies

| LOWER LEVEL GREENBERG BUILDING (CRC)

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Chemical Biology Approaches to Define Immunomodulatory Protease Functions

| 116 ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.